Indication
Recrudescent typhus
Recrudescent typhus, classically known as Brill-Zinsser disease, is a delayed, relapsing systemic infection caused by the reactivation of dormant *Rickettsia prowazekii* years or decades after an initial bout of epidemic louse-borne typhus. Read more about Recrudescent typhus
150 drugs 90 manufacturers
Drugs that treat it
Common Recrudescent typhus therapies.
DOXYCYCLINE HYCLATE
DOXYCYCLINE MONOHYDRATE
DOXYCYCLINE HYCLATE
DOXYCYCLINE HYCLATE
DOXYCYCLINE HYCLATE
DOXYCYCLINE HYCLATE
DOXYCYCLINE HYCLATE
DOXYCYCLINE HYCLATE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonRecrudescent typhus, classically known as Brill-Zinsser disease, is a delayed, relapsing systemic infection caused by the reactivation of dormant *Rickettsia prowazekii* years or decades after an initial bout of epidemic louse-borne typhus.
It primarily affects adults or elderly individuals who previously resided in endemic areas or experienced untreated primary epidemic typhus, often reactivating during periods of physiologic stress, nutritional compromise, or waning cell-mediated immunity.
Pathophysiologically, the bacteria persist within host endothelial and reticuloendothelial cells, with reactivation producing a milder systemic vasculitis compared to primary infection.
Defining clinical features include acute fever, chills, severe headache, and malaise, occasionally accompanied by a transient, faint maculopapular rash, while serving epidemiologically as an interepidemic human reservoir capable of transmitting the pathogen to lice.
- cdc.gov
Recrudescent typhus, classically known as Brill-Zinsser disease, is a delayed, relapsing systemic infection caused by the reactivation of dormant *Rickettsia prowazekii* years or decades after an initial bout of epidemic louse-borne typhus It primarily affects adults or elderly individuals who previously resided in endemic areas or experienced untreated primary epidemic typhus, often reactivating during periods of physiologic stress, nutritional compromise, or waning cell-mediated immunity Patho...
- merckmanuals.com
Recrudescent typhus, classically known as Brill-Zinsser disease, is a delayed, relapsing systemic infection caused by the reactivation of dormant *Rickettsia prowazekii* years or decades after an initial bout of epidemic louse-borne typhus It primarily affects adults or elderly individuals who previously resided in endemic areas or experienced untreated primary epidemic typhus, often reactivating during periods of physiologic stress, nutritional compromise, or waning cell-mediated immunity
- merckmanuals.com
It primarily affects adults or elderly individuals who previously resided in endemic areas or experienced untreated primary epidemic typhus, often reactivating during periods of physiologic stress, nutritional compromise, or waning cell-mediated immunity
- wikipedia.org
Pathophysiologically, the bacteria persist within host endothelial and reticuloendothelial cells, with reactivation producing a milder systemic vasculitis compared to primary infection
- nih.gov
Pathophysiologically, the bacteria persist within host endothelial and reticuloendothelial cells, with reactivation producing a milder systemic vasculitis compared to primary infection Defining clinical features include acute fever, chills, severe headache, and malaise, occasionally accompanied by a transient, faint maculopapular rash, while serving epidemiologically as an interepidemic human reservoir capable of transmitting the pathogen to lice
- nih.gov
Defining clinical features include acute fever, chills, severe headache, and malaise, occasionally accompanied by a transient, faint maculopapular rash, while serving epidemiologically as an interepidemic human reservoir capable of transmitting the pathogen to lice
Personalize your experience
Follow Recrudescent typhus and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.